Division of Surgery, Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gynecol Oncol. 2019 Aug;154(2):405-410. doi: 10.1016/j.ygyno.2019.06.003. Epub 2019 Jun 14.
The Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) is a national survey of inpatient experience. This study evaluated the association between HCAHPS survey results and outcomes in gynecologic cancer surgery.
This observational study used HCAHPS survey data from 2009 to 2011 to assign hospitals into score terciles. The Nationwide Inpatient Sample (NIS) database was used to identify admissions during the same time period for gynecologic cancer-specific surgeries. Data sources were linked at the hospital level. Postoperative complications, mortality, and prolonged length of stay were compared between higher and lower scoring hospitals. Complications were grouped as 'surgical', 'medical', or 'care team'. Mixed effects models were used to evaluate the associations between hospitals' HCAHPS scores and outcomes after adjustment for patient and hospital-level variables.
17,509 linked encounters in 651 hospitals across the U.S. were identified, with 51% uterine, 40% ovarian, and 9% cervical cancer surgical admissions. In-hospital mortality was lower in hospitals in the top HCAHPS score terciles compared to bottom HCAHPS score tercile (odds ratio (OR) 0.54, 95% CI: 0.31-0.94). Surgery in higher scoring HCAHPS hospitals was associated with less 'surgical' complications (OR 0.82, 95% CI 0.69-0.98). No association was found between 'medical', 'care team', overall complications, or prolonged hospitalization (p > 0.05) and HCAHPS scores.
Gynecologic oncology surgeries performed in top HCAHPS tercile hospitals were associated with lower in-hospital mortality and surgical complications compared to surgeries performed in bottom tercile hospitals. Associations between HCAHPS scores and other adverse events were not seen.
医疗机构患者评估调查(HCAHPS)是一项全国性的住院患者体验调查。本研究评估了 HCAHPS 调查结果与妇科癌症手术结果之间的关系。
本观察性研究使用了 2009 年至 2011 年的 HCAHPS 调查数据,将医院分为评分三分位数。使用全国住院患者样本(NIS)数据库确定了同期进行妇科癌症特定手术的住院患者。在医院层面上对数据来源进行了链接。比较了评分较高和较低的医院之间的术后并发症、死亡率和住院时间延长情况。并发症分为“手术相关”、“医疗相关”或“医护团队相关”。使用混合效应模型,在校正了患者和医院层面的变量后,评估了医院 HCAHPS 评分与结果之间的关系。
在美国 651 家医院中,共确定了 17509 例相关病例,其中 51%为子宫癌、40%为卵巢癌、9%为宫颈癌手术。与 HCAHPS 评分最低的三分位数相比,HCAHPS 评分最高的三分位数中院内死亡率较低(比值比(OR)0.54,95%可信区间:0.31-0.94)。在 HCAHPS 评分较高的医院进行手术与较少的“手术相关”并发症相关(OR 0.82,95%可信区间 0.69-0.98)。未发现 HCAHPS 评分与“医疗相关”、“医护团队相关”、总体并发症或住院时间延长之间存在关联(p>0.05)。
与在 HCAHPS 评分最低的三分位数中进行手术的患者相比,在 HCAHPS 评分最高的三分位数中进行妇科肿瘤手术的患者,院内死亡率和手术并发症较低。未发现 HCAHPS 评分与其他不良事件之间存在关联。